Christopher Vann
Chief Operating Officer chez AUTOLUS THERAPEUTICS PLC
Fortune : 715 906 $ au 31/03/2024
Profil
Christopher Vann is currently the Treasurer & Director at Alliance for Regenerative Medicine since 2023.
He is also the Chief Operating Officer & Senior Vice President at Autolus Therapeutics Plc since 2016.
Previously, he worked at Roche Holding AG as the Commercial Director from 1994 to 2016.
Mr. Vann completed his undergraduate degree at the School of Pharmacy.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
AUTOLUS THERAPEUTICS PLC
0,07% | 01/03/2023 | 112 211 ( 0,07% ) | 715 906 $ | 31/03/2024 |
Postes actifs de Christopher Vann
Sociétés | Poste | Début |
---|---|---|
AUTOLUS THERAPEUTICS PLC | Chief Operating Officer | 01/10/2016 |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Director/Board Member | 01/01/2021 |
Anciens postes connus de Christopher Vann
Sociétés | Poste | Fin |
---|---|---|
ROCHE HOLDING AG | Corporate Officer/Principal | 01/09/2016 |
Formation de Christopher Vann
School of Pharmacy | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
ROCHE HOLDING AG | Health Technology |
AUTOLUS THERAPEUTICS PLC | Health Technology |
Entreprise privées | 1 |
---|---|
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Health Services |